- Home
- PRPO vs CYCN Comparison
PRPO vs CYCN Comparison
Compare PRPO & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- CYCN
- Stock Information
- Founded
- PRPO N/A
- CYCN 2018
- Country
- PRPO United States
- CYCN United States
- Employees
- PRPO N/A
- CYCN N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- CYCN Health Care
- Exchange
- PRPO Nasdaq
- CYCN Nasdaq
- Market Cap
- PRPO N/A
- CYCN 6.5M
- IPO Year
- PRPO N/A
- CYCN N/A
- Fundamental
- Price
- PRPO $16.00
- CYCN $3.14
- Analyst Decision
- PRPO
- CYCN
- Analyst Count
- PRPO 0
- CYCN 0
- Target Price
- PRPO N/A
- CYCN N/A
- AVG Volume (30 Days)
- PRPO 13.9K
- CYCN 25.9K
- Earning Date
- PRPO 08-12-2025
- CYCN 08-06-2025
- Dividend Yield
- PRPO N/A
- CYCN N/A
- EPS Growth
- PRPO N/A
- CYCN N/A
- EPS
- PRPO N/A
- CYCN N/A
- Revenue
- PRPO $20,029,000.00
- CYCN $2,081,000.00
- Revenue This Year
- PRPO N/A
- CYCN N/A
- Revenue Next Year
- PRPO N/A
- CYCN N/A
- P/E Ratio
- PRPO N/A
- CYCN N/A
- Revenue Growth
- PRPO 26.67
- CYCN N/A
- 52 Week Low
- PRPO $3.90
- CYCN $1.27
- 52 Week High
- PRPO $16.50
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- PRPO 79.61
- CYCN 52.20
- Support Level
- PRPO $10.60
- CYCN $3.02
- Resistance Level
- PRPO $11.70
- CYCN $3.50
- Average True Range (ATR)
- PRPO 0.73
- CYCN 0.28
- MACD
- PRPO 0.26
- CYCN 0.02
- Stochastic Oscillator
- PRPO 99.16
- CYCN 54.43
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.